| 05/08/24 | 17:42:34 | 5 Aug 2024 | | Transaction in Own Shares | RNS |
| 02/08/24 | 18:21:22 | 2 Aug 2024 | | Transaction in Own Shares | RNS |
| 01/08/24 | 07:05:00 | 1 Aug 2024 | | Commencement of On-Market Share Buyback Programme | RNS |
| 01/08/24 | 07:00:07 | 1 Aug 2024 | | Haleon 2024 Half Year Results | RNS |
| 26/06/24 | 12:45:00 | 26 Jun 2024 | | Divestment of NRT business outside of the US | RNS |
| 31/05/24 | 16:47:07 | 31 May 2024 | | Disposal of the ChapStick brand completed | RNS |
| 23/05/24 | 17:15:00 | 23 May 2024 | | Director/PDMR Shareholding | RNS |
| 20/05/24 | 14:45:01 | 20 May 2024 | | Holding(s) in Company | RNS |
| 20/05/24 | 14:15:00 | 20 May 2024 | | Director/PDMR Shareholding | RNS |
| 17/05/24 | 17:30:00 | 17 May 2024 | | Haleon | RNS |
| 08/05/24 | 17:15:01 | 8 May 2024 | | Results of Haleon 2024 Annual General Meeting | RNS |
| 07/05/24 | 09:30:01 | 7 May 2024 | | EMTN programme: publication of base prospectus | RNS |
| 01/05/24 | 11:10:01 | 1 May 2024 | | Directorate Change | RNS |
| 01/05/24 | 07:00:09 | 1 May 2024 | | Haleon 2024 Q1 Trading Statement | RNS |
| 24/04/24 | 07:00:13 | 24 Apr 2024 | | Appointment of Dawn Allen as CFO | RNS |
| 12/04/24 | 12:00:00 | 12 Apr 2024 | | Notice of Annual General Meeting (AGM) | RNS |
| 03/04/24 | 11:30:01 | 3 Apr 2024 | | Director/PDMR Shareholding | RNS |
| 02/04/24 | 09:15:00 | 2 Apr 2024 | | Total Voting Rights and Capital | RNS |
| 22/03/24 | 11:30:00 | 22 Mar 2024 | | Holding(s) in Company | RNS |
| 21/03/24 | 18:00:00 | 21 Mar 2024 | | Haleon | RNS |
| 21/03/24 | 16:38:22 | 21 Mar 2024 | | Total Voting Rights and Capital | RNS |
| 21/03/24 | 16:05:33 | 21 Mar 2024 | | Closing of Secondary Global Offering by Pfizer | RNS |
| 20/03/24 | 08:39:50 | 20 Mar 2024 | | Final prospectus supplement filed with the SEC | RNS |
| 19/03/24 | 07:00:10 | 19 Mar 2024 | | Pricing and upsize of Secondary Global Offering | RNS |
| 18/03/24 | 11:00:04 | 18 Mar 2024 | | Preliminary prospectus supplement filed with SEC | RNS |
| 18/03/24 | 07:00:07 | 18 Mar 2024 | | Proposed Secondary Global Offering by Pfizer Inc. | RNS |
| 15/03/24 | 15:00:00 | 15 Mar 2024 | | Publication of Annual Report and Form 20-F 2023 | RNS |
| 14/03/24 | 16:20:00 | 14 Mar 2024 | | Director/PDMR Shareholding | RNS |
| 12/03/24 | 15:30:00 | 12 Mar 2024 | | Director/PDMR Shareholding | RNS |
| 05/03/24 | 14:30:00 | 5 Mar 2024 | | Director/PDMR Shareholding | RNS |
| 29/02/24 | 07:00:04 | 29 Feb 2024 | | Haleon Preliminary 2023 Full Year Results | RNS |
| 12/02/24 | 16:15:00 | 12 Feb 2024 | | Director/PDMR Shareholding | RNS |
| 02/02/24 | 14:15:00 | 2 Feb 2024 | | Director Declaration | RNS |
| 25/01/24 | 07:00:07 | 25 Jan 2024 | | Haleon to sell ChapStick | RNS |
| 18/01/24 | 17:00:00 | 18 Jan 2024 | | Holding(s) in Company | RNS |
| 17/01/24 | 18:00:00 | 17 Jan 2024 | | Haleon | RNS |
| 11/01/24 | 13:00:00 | 11 Jan 2024 | | Director/PDMR Shareholding | RNS |
| 19/12/23 | 13:00:00 | 19 Dec 2023 | | Director/PDMR Shareholding | RNS |
| 13/12/23 | 10:30:01 | 13 Dec 2023 | | Director/PDMR Shareholding | RNS |
| 10/11/23 | 13:00:01 | 10 Nov 2023 | | Director/PDMR Shareholding | RNS |
| 02/11/23 | 07:00:07 | 2 Nov 2023 | | Haleon 2023 Q3 Trading Statement | RNS |
| 13/10/23 | 15:30:00 | 13 Oct 2023 | | Director/PDMR Shareholding | RNS |
| 11/10/23 | 15:00:01 | 11 Oct 2023 | | Director/PDMR Shareholding | RNS |
| 10/10/23 | 11:00:01 | 10 Oct 2023 | | Holding(s) in Company | RNS |
| 06/10/23 | 18:00:01 | 6 Oct 2023 | | Haleon | RNS |
| 06/10/23 | 14:30:01 | 6 Oct 2023 | | Director/PDMR Shareholding | RNS |
| 28/09/23 | 11:00:02 | 28 Sept 2023 | | Director Declaration | RNS |
| 13/09/23 | 09:30:01 | 13 Sept 2023 | | Director/PDMR Shareholding | RNS |
| 10/08/23 | 13:00:01 | 10 Aug 2023 | | Director/PDMR Shareholding | RNS |
| 02/08/23 | 07:00:04 | 2 Aug 2023 | | Haleon Half Year Results 2023 | RNS |
